Atlas Logo
Cognitive Health in Ageing Register: Investigational, Observational, and Trial studies in dementia research (CHARIOT): Prospective Readiness cOhort Study (PRO) Sub Study (CPSS)
BACK
Sample details

CPSS aimed to characterise non-symptomatic Alzheimer's Disease (AD) and related cognitive impairments. Recruited participants were cognitively normal participants aged 60-85 from Greater London and Edinburgh. The cohort consists of elderly adults classified as high, medium, or low risk for developing mild cognitive impairment–Alzheimer's disease based on screening assessments. Over 1,000 participants completed the baseline data collection. Participants were followed up quarterly until the end of the study.

Study design
Cohort - clinical

Number of participants at first data collection

1,136 (participants)

Age at first data collection

60 - 85 years (participants)

Participant year of birth

Varied (participants)

Participant sex
All

Representative sample at baseline?
No

Sample features

Older and elderly people
Dataset details
Loading map...

Countries

England, Scotland, United Kingdom of Great Britain and Northern Ireland

Year of first data collection

2015

Primary Institutions

Imperial College London (Imperial, ICL)

Janssen Pharmaceutical Research & Development LLC

University of Edinburgh (University o Edinburgh, Oilthigh Dhùn Èideann)

Links

portal.dementiasplatform.uk/CohortDirectory/Item

clinicaltrials.gov/study/NCT02114372

Funders

Janssen Pharmaceutical Research & Development LLC

Ongoing?
No

Data types collected

neuroImagingData
mentalHealthData
Quantitative data collection
  • Activity log (e.g. food, sleep, exercise)
  • Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
  • Interview – face-to-face
  • Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
  • Self-report questionnaire – unspecified
  • Wearable devices
Qualitative data collection
  • None
Neuroimaging data collection
  • Diffusion Tensor Imaging (DTI)
  • Functional magnetic resonance imaging (fMRI)
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET)
Linked or secondary data
  • None
Features

Engagement

  • None
  • Keywords

    Alzheimer's disease (AD)
    Biological samples/biospecimens
    Cognitive assessments
    Dementia
    Diet and nutrition
    Lifestyle factors
    Mild cognitive impairment (MCI)
    Neuroimaging
    Sleep
    Contact us

    |

    FAQS

    |

    Privacy

    |

    © 2024 Louise Arseneault

    Platform by Delosis